Consistent with a role for CDH4 in the metastatic process suggested by findings in other cancer types, we found that transcriptional co-option of THE1 A[CDH4-AS] specifically in SCKM differentiates primary and metastatic disease and is differentially associated with survival in the two subtypes (Fig. 3D). The gene discussed is CDH4; the disease is metastatic neoplasm.